Open AccessEffectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
Author(s) -
Ooshiro Daisuke,
Yamaguchi Satoshi,
Kakazu Masanori,
Arasaki Osamu
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.830
Subject(s) - medicine , fasudil , nicorandil , ventricular fibrillation , cardiopulmonary resuscitation , cardiology , myocardial infarction , anesthesia , chest pain , percutaneous coronary intervention , resuscitation , biochemistry , signal transduction , chemistry , rho associated protein kinase
Key Clinical Message Refractory coronary vasospasm subsequent to reperfusion, such as cardiopulmonary resuscitation or revascularization, for myocardial infarction may respond to fasudil in the superacute phase. Continuous low‐dose fasudil administration should be an option for refractory coronary vasospastic angina (VSA).